Age-dependent  ||| S:0 E:14 ||| JJ
characteristics  ||| S:14 E:30 ||| NNS
of  ||| S:30 E:33 ||| IN
nutritional  ||| S:33 E:45 ||| JJ
status  ||| S:45 E:52 ||| NN
and  ||| S:52 E:56 ||| CC
resting  ||| S:56 E:64 ||| JJ
metabolism  ||| S:64 E:75 ||| NN
in  ||| S:75 E:78 ||| IN
overweight  ||| S:78 E:89 ||| NN
and  ||| S:89 E:93 ||| CC
obese  ||| S:93 E:99 ||| JJ
children  ||| S:99 E:108 ||| NNS
The  ||| S:108 E:112 ||| DT
age-dependent  ||| S:112 E:126 ||| JJ
nutritional  ||| S:126 E:138 ||| JJ
status  ||| S:138 E:145 ||| NN
and  ||| S:145 E:149 ||| CC
resting  ||| S:149 E:157 ||| JJ
metabolism  ||| S:157 E:168 ||| NN
in  ||| S:168 E:171 ||| IN
overweight  ||| S:171 E:182 ||| NN
and  ||| S:182 E:186 ||| CC
obese  ||| S:186 E:192 ||| JJ
children  ||| S:192 E:201 ||| NNS
have  ||| S:201 E:206 ||| VBP
been  ||| S:206 E:211 ||| VBN
examined ||| S:211 E:219 ||| VBN
.  ||| S:219 E:221 ||| .
The  ||| S:221 E:225 ||| DT
study  ||| S:225 E:231 ||| NN
included  ||| S:231 E:240 ||| VBD
625  ||| S:240 E:244 ||| CD
children  ||| S:244 E:253 ||| NNS
of  ||| S:253 E:256 ||| IN
2.5-17  ||| S:256 E:263 ||| CD
years  ||| S:263 E:269 ||| NNS
old ||| S:269 E:272 ||| JJ
.  ||| S:272 E:274 ||| .
Patients  ||| S:274 E:283 ||| NNS
were  ||| S:283 E:288 ||| VBD
divided  ||| S:288 E:296 ||| VBN
into  ||| S:296 E:301 ||| IN
three  ||| S:301 E:307 ||| CD
groups ||| S:307 E:313 ||| NNS
:  ||| S:313 E:315 ||| :
1st--2.5-7  ||| S:315 E:326 ||| CD
years  ||| S:326 E:332 ||| NNS
old  ||| S:332 E:336 ||| JJ
( ||| S:336 E:337 ||| -LRB-
n  ||| S:337 E:339 ||| CD
=  ||| S:339 E:341 ||| SYM
49 ||| S:341 E:343 ||| CD
) ||| S:343 E:344 ||| -RRB-
,  ||| S:344 E:346 ||| ,
2nd--8-12  ||| S:346 E:356 ||| CD
years  ||| S:356 E:362 ||| NNS
old  ||| S:362 E:366 ||| JJ
( ||| S:366 E:367 ||| -LRB-
n  ||| S:367 E:369 ||| CD
=  ||| S:369 E:371 ||| SYM
204 ||| S:371 E:374 ||| CD
) ||| S:374 E:375 ||| -RRB-
,  ||| S:375 E:377 ||| ,
3rd--13-17  ||| S:377 E:388 ||| CD
years  ||| S:388 E:394 ||| NNS
old  ||| S:394 E:398 ||| JJ
( ||| S:398 E:399 ||| -LRB-
n  ||| S:399 E:401 ||| CD
=  ||| S:401 E:403 ||| SYM
372 ||| S:403 E:406 ||| CD
) ||| S:406 E:407 ||| -RRB-
.  ||| S:407 E:409 ||| .
The  ||| S:409 E:413 ||| DT
diagnosis  ||| S:413 E:423 ||| NN
of  ||| S:423 E:426 ||| IN
overweight  ||| S:426 E:437 ||| NN
and  ||| S:437 E:441 ||| CC
obesity  ||| S:441 E:449 ||| NNS
was  ||| S:449 E:453 ||| VBD
based  ||| S:453 E:459 ||| VBN
on  ||| S:459 E:462 ||| IN
CDC  ||| S:462 E:466 ||| NNP
criteria ||| S:466 E:474 ||| NNS
:  ||| S:474 E:476 ||| :
children  ||| S:476 E:485 ||| NNS
with  ||| S:485 E:490 ||| IN
85-94  ||| S:490 E:496 ||| NNP
BMI  ||| S:496 E:500 ||| NNP
percentile  ||| S:500 E:511 ||| VBZ
according  ||| S:511 E:521 ||| VBG
to  ||| S:521 E:524 ||| TO
age  ||| S:524 E:528 ||| NN
and  ||| S:528 E:532 ||| CC
gender  ||| S:532 E:539 ||| NN
had  ||| S:539 E:543 ||| VBD
overweight ||| S:543 E:553 ||| CD
,  ||| S:553 E:555 ||| ,
BMI  ||| S:555 E:559 ||| NNP
295  ||| S:559 E:563 ||| CD
percentile--obesity ||| S:563 E:582 ||| NN
.  ||| S:582 E:584 ||| .
Anthropometry ||| S:584 E:597 ||| NNP
,  ||| S:597 E:599 ||| ,
bioelectric  ||| S:599 E:611 ||| JJ
impedance  ||| S:611 E:621 ||| JJ
analysis  ||| S:621 E:630 ||| NN
and  ||| S:630 E:634 ||| CC
indirect  ||| S:634 E:643 ||| JJ
respiratory  ||| S:643 E:655 ||| JJ
calorimetry  ||| S:655 E:667 ||| NN
were  ||| S:667 E:672 ||| VBD
performed ||| S:672 E:681 ||| VBN
;  ||| S:681 E:683 ||| :
lipid  ||| S:683 E:689 ||| NNS
and  ||| S:689 E:693 ||| CC
carbohydrate  ||| S:693 E:706 ||| JJ
parameters  ||| S:706 E:717 ||| NNS
were  ||| S:717 E:722 ||| VBD
measured ||| S:722 E:730 ||| VBN
.  ||| S:730 E:732 ||| .
The  ||| S:732 E:736 ||| DT
fat  ||| S:736 E:740 ||| JJ
mass  ||| S:740 E:745 ||| NN
percentages  ||| S:745 E:757 ||| NNS
in  ||| S:757 E:760 ||| IN
children  ||| S:760 E:769 ||| NNS
of  ||| S:769 E:772 ||| IN
studed  ||| S:772 E:779 ||| JJ
groups  ||| S:779 E:786 ||| NNS
were  ||| S:786 E:791 ||| VBD
41.3  ||| S:791 E:796 ||| CD
±  ||| S:796 E:798 ||| CD
1.9 ||| S:798 E:801 ||| CD
,  ||| S:801 E:803 ||| ,
39.8  ||| S:803 E:808 ||| CD
±  ||| S:808 E:810 ||| CD
0.7  ||| S:810 E:814 ||| CD
and  ||| S:814 E:818 ||| CC
42.3  ||| S:818 E:823 ||| CD
±  ||| S:823 E:825 ||| CD
0.4 ||| S:825 E:828 ||| CD
% ||| S:828 E:829 ||| NN
,  ||| S:829 E:831 ||| ,
the  ||| S:831 E:835 ||| DT
mean  ||| S:835 E:840 ||| JJ
percent  ||| S:840 E:848 ||| NN
of  ||| S:848 E:851 ||| IN
fat  ||| S:851 E:855 ||| JJ
mass  ||| S:855 E:860 ||| NN
excess--163.6  ||| S:860 E:874 ||| CD
±  ||| S:874 E:876 ||| CD
26.2 ||| S:876 E:880 ||| CD
,  ||| S:880 E:882 ||| ,
113.7  ||| S:882 E:888 ||| CD
±  ||| S:888 E:890 ||| CD
8.3  ||| S:890 E:894 ||| CD
and  ||| S:894 E:898 ||| CC
134.9  ||| S:898 E:904 ||| CD
±  ||| S:904 E:906 ||| CD
8.2 ||| S:906 E:909 ||| CD
%  ||| S:909 E:911 ||| NN
respectively ||| S:911 E:923 ||| RB
,  ||| S:923 E:925 ||| ,
p  ||| S:925 E:927 ||| CD
>  ||| S:927 E:929 ||| CD
0.05 ||| S:929 E:933 ||| CD
.  ||| S:933 E:935 ||| .
Prevalence  ||| S:935 E:946 ||| NNP
of  ||| S:946 E:949 ||| IN
dyslipidemia  ||| S:949 E:962 ||| NN
in  ||| S:962 E:965 ||| IN
children  ||| S:965 E:974 ||| NNS
increased  ||| S:974 E:984 ||| VBN
with  ||| S:984 E:989 ||| IN
age ||| S:989 E:992 ||| NN
:  ||| S:992 E:994 ||| :
lipid  ||| S:994 E:1000 ||| JJ
metabolism  ||| S:1000 E:1011 ||| NN
disorders  ||| S:1011 E:1021 ||| NNS
were  ||| S:1021 E:1026 ||| VBD
revealed  ||| S:1026 E:1035 ||| VBN
in  ||| S:1035 E:1038 ||| IN
28.6 ||| S:1038 E:1042 ||| CD
,  ||| S:1042 E:1044 ||| ,
49.0  ||| S:1044 E:1049 ||| CD
u  ||| S:1049 E:1051 ||| CD
53.2 ||| S:1051 E:1055 ||| CD
%  ||| S:1055 E:1057 ||| NN
children  ||| S:1057 E:1066 ||| NNS
of  ||| S:1066 E:1069 ||| IN
the  ||| S:1069 E:1073 ||| DT
1st ||| S:1073 E:1076 ||| CD
,  ||| S:1076 E:1078 ||| ,
2nd  ||| S:1078 E:1082 ||| NNP
and  ||| S:1082 E:1086 ||| CC
3rd  ||| S:1086 E:1090 ||| CD
groups  ||| S:1090 E:1097 ||| NNS
respectively ||| S:1097 E:1109 ||| RB
.  ||| S:1109 E:1111 ||| .
The  ||| S:1111 E:1115 ||| DT
mean  ||| S:1115 E:1120 ||| JJ
HDL  ||| S:1120 E:1124 ||| NNP
level  ||| S:1124 E:1130 ||| NN
in  ||| S:1130 E:1133 ||| IN
the  ||| S:1133 E:1137 ||| DT
1st  ||| S:1137 E:1141 ||| CD
and  ||| S:1141 E:1145 ||| CC
2nd  ||| S:1145 E:1149 ||| CD
groups  ||| S:1149 E:1156 ||| NNS
was  ||| S:1156 E:1160 ||| VBD
significantly  ||| S:1160 E:1174 ||| RB
higher ||| S:1174 E:1180 ||| JJR
,  ||| S:1180 E:1182 ||| ,
and  ||| S:1182 E:1186 ||| CC
triglycerides--lower  ||| S:1186 E:1207 ||| JJ
than  ||| S:1207 E:1212 ||| IN
in  ||| S:1212 E:1215 ||| IN
the  ||| S:1215 E:1219 ||| DT
3rd  ||| S:1219 E:1223 ||| JJ
group ||| S:1223 E:1228 ||| NN
.  ||| S:1228 E:1230 ||| .
The  ||| S:1230 E:1234 ||| DT
correlation  ||| S:1234 E:1246 ||| NN
of  ||| S:1246 E:1249 ||| IN
HDL  ||| S:1249 E:1253 ||| NNP
level  ||| S:1253 E:1259 ||| NN
and  ||| S:1259 E:1263 ||| CC
breastfeeding  ||| S:1263 E:1277 ||| JJ
duration  ||| S:1277 E:1286 ||| NN
( ||| S:1286 E:1287 ||| -LRB-
r1  ||| S:1287 E:1290 ||| CD
=  ||| S:1290 E:1292 ||| SYM
0.94 ||| S:1292 E:1296 ||| CD
,  ||| S:1296 E:1298 ||| ,
p  ||| S:1298 E:1300 ||| CD
< ||| S:1300 E:1302 ||| SYM
0.05 ||| S:1302 E:1306 ||| CD
)  ||| S:1306 E:1308 ||| -RRB-
was  ||| S:1308 E:1312 ||| VBD
found  ||| S:1312 E:1318 ||| VBN
in  ||| S:1318 E:1321 ||| IN
the  ||| S:1321 E:1325 ||| DT
1st  ||| S:1325 E:1329 ||| CD
group  ||| S:1329 E:1335 ||| NN
of  ||| S:1335 E:1338 ||| IN
children ||| S:1338 E:1346 ||| NNS
.  ||| S:1346 E:1348 ||| .
Increased  ||| S:1348 E:1358 ||| JJ
insulin  ||| S:1358 E:1366 ||| NN
level  ||| S:1366 E:1372 ||| NN
was  ||| S:1372 E:1376 ||| VBD
revealed  ||| S:1376 E:1385 ||| VBN
in  ||| S:1385 E:1388 ||| IN
38.8 ||| S:1388 E:1392 ||| CD
%  ||| S:1392 E:1394 ||| NN
children  ||| S:1394 E:1403 ||| NNS
in  ||| S:1403 E:1406 ||| IN
the  ||| S:1406 E:1410 ||| DT
1st  ||| S:1410 E:1414 ||| CD
group  ||| S:1414 E:1420 ||| NN
( ||| S:1420 E:1421 ||| -LRB-
mean  ||| S:1421 E:1426 ||| VB
12.8  ||| S:1426 E:1431 ||| CD
±  ||| S:1431 E:1433 ||| CD
1.4  ||| S:1433 E:1437 ||| CD
μIU ||| S:1437 E:1440 ||| JJ
/ ||| S:1440 E:1441 ||| CD
ml ||| S:1441 E:1443 ||| CD
) ||| S:1443 E:1444 ||| -RRB-
,  ||| S:1444 E:1446 ||| ,
62.2 ||| S:1446 E:1450 ||| CD
%  ||| S:1450 E:1452 ||| NN
children  ||| S:1452 E:1461 ||| NNS
in  ||| S:1461 E:1464 ||| IN
the  ||| S:1464 E:1468 ||| DT
2nd  ||| S:1468 E:1472 ||| JJ
group  ||| S:1472 E:1478 ||| NN
( ||| S:1478 E:1479 ||| -LRB-
21.1  ||| S:1479 E:1484 ||| CD
±  ||| S:1484 E:1486 ||| CD
0.7  ||| S:1486 E:1490 ||| CD
μIU ||| S:1490 E:1493 ||| JJ
/ ||| S:1493 E:1494 ||| CD
ml ||| S:1494 E:1496 ||| CD
)  ||| S:1496 E:1498 ||| -RRB-
and  ||| S:1498 E:1502 ||| CC
64.8 ||| S:1502 E:1506 ||| CD
%  ||| S:1506 E:1508 ||| NN
children  ||| S:1508 E:1517 ||| NNS
in  ||| S:1517 E:1520 ||| IN
the  ||| S:1520 E:1524 ||| DT
3rd  ||| S:1524 E:1528 ||| JJ
group  ||| S:1528 E:1534 ||| NN
( ||| S:1534 E:1535 ||| -LRB-
25.1  ||| S:1535 E:1540 ||| FW
±  ||| S:1540 E:1542 ||| FW
0.9  ||| S:1542 E:1546 ||| FW
μIU ||| S:1546 E:1549 ||| FW
/ ||| S:1549 E:1550 ||| FW
ml ||| S:1550 E:1552 ||| FW
) ||| S:1552 E:1553 ||| -RRB-
;  ||| S:1553 E:1555 ||| :
increased  ||| S:1555 E:1565 ||| VBD
HOMA--in  ||| S:1565 E:1574 ||| JJ
36.7 ||| S:1574 E:1578 ||| CD
%  ||| S:1578 E:1580 ||| NN
( ||| S:1580 E:1581 ||| -LRB-
4.32  ||| S:1581 E:1586 ||| CD
±  ||| S:1586 E:1588 ||| CD
0.6 ||| S:1588 E:1591 ||| CD
) ||| S:1591 E:1592 ||| -RRB-
,  ||| S:1592 E:1594 ||| ,
62.2 ||| S:1594 E:1598 ||| CD
%  ||| S:1598 E:1600 ||| NN
( ||| S:1600 E:1601 ||| -LRB-
4.65  ||| S:1601 E:1606 ||| CD
±  ||| S:1606 E:1608 ||| CD
0.17 ||| S:1608 E:1612 ||| CD
)  ||| S:1612 E:1614 ||| -RRB-
and  ||| S:1614 E:1618 ||| CC
59.1 ||| S:1618 E:1622 ||| CD
%  ||| S:1622 E:1624 ||| NN
( ||| S:1624 E:1625 ||| -LRB-
5.56  ||| S:1625 E:1630 ||| CD
±  ||| S:1630 E:1632 ||| CD
0.21 ||| S:1632 E:1636 ||| CD
)  ||| S:1636 E:1638 ||| -RRB-
respectively ||| S:1638 E:1650 ||| RB
.  ||| S:1650 E:1652 ||| .
The  ||| S:1652 E:1656 ||| DT
negative  ||| S:1656 E:1665 ||| JJ
correlation  ||| S:1665 E:1677 ||| NN
of  ||| S:1677 E:1680 ||| IN
insulin  ||| S:1680 E:1688 ||| NN
and  ||| S:1688 E:1692 ||| CC
HOMA  ||| S:1692 E:1697 ||| NNP
level  ||| S:1697 E:1703 ||| NN
with  ||| S:1703 E:1708 ||| IN
breastfeeding  ||| S:1708 E:1722 ||| JJ
duration  ||| S:1722 E:1731 ||| NN
( ||| S:1731 E:1732 ||| -LRB-
r1  ||| S:1732 E:1735 ||| NNP
=  ||| S:1735 E:1737 ||| NNP
-0.38  ||| S:1737 E:1743 ||| NNP
and  ||| S:1743 E:1747 ||| CC
-0.37 ||| S:1747 E:1752 ||| NNP
,  ||| S:1752 E:1754 ||| ,
respectively ||| S:1754 E:1766 ||| RB
,  ||| S:1766 E:1768 ||| ,
p  ||| S:1768 E:1770 ||| CD
< ||| S:1770 E:1772 ||| SYM
0.05 ||| S:1772 E:1776 ||| CD
)  ||| S:1776 E:1778 ||| -RRB-
was  ||| S:1778 E:1782 ||| VBD
found  ||| S:1782 E:1788 ||| VBN
in  ||| S:1788 E:1791 ||| IN
the  ||| S:1791 E:1795 ||| DT
1st  ||| S:1795 E:1799 ||| CD
group  ||| S:1799 E:1805 ||| NN
of  ||| S:1805 E:1808 ||| IN
children ||| S:1808 E:1816 ||| NNS
.  ||| S:1816 E:1818 ||| .
Prevalence  ||| S:1818 E:1829 ||| NNP
of  ||| S:1829 E:1832 ||| IN
hyperuricemia  ||| S:1832 E:1846 ||| VBG
increased  ||| S:1846 E:1856 ||| VBN
from  ||| S:1856 E:1861 ||| IN
13 ||| S:1861 E:1863 ||| CD
%  ||| S:1863 E:1865 ||| NN
in  ||| S:1865 E:1868 ||| IN
the  ||| S:1868 E:1872 ||| DT
1st  ||| S:1872 E:1876 ||| CD
group  ||| S:1876 E:1882 ||| NN
to  ||| S:1882 E:1885 ||| TO
21.1 ||| S:1885 E:1889 ||| CD
%  ||| S:1889 E:1891 ||| NN
in  ||| S:1891 E:1894 ||| IN
the  ||| S:1894 E:1898 ||| DT
2nd  ||| S:1898 E:1902 ||| NNP
and  ||| S:1902 E:1906 ||| CC
44.1 ||| S:1906 E:1910 ||| CD
%  ||| S:1910 E:1912 ||| NN
in  ||| S:1912 E:1915 ||| IN
the  ||| S:1915 E:1919 ||| DT
3rd  ||| S:1919 E:1923 ||| JJ
group ||| S:1923 E:1928 ||| NN
.  ||| S:1928 E:1930 ||| .
Prevalence  ||| S:1930 E:1941 ||| NNP
and  ||| S:1941 E:1945 ||| CC
degree  ||| S:1945 E:1952 ||| NN
of  ||| S:1952 E:1955 ||| IN
resting  ||| S:1955 E:1963 ||| JJ
metabolism  ||| S:1963 E:1974 ||| NN
changes  ||| S:1974 E:1982 ||| NNS
increased  ||| S:1982 E:1992 ||| VBN
with  ||| S:1992 E:1997 ||| IN
age  ||| S:1997 E:2001 ||| NN
and  ||| S:2001 E:2005 ||| CC
had  ||| S:2005 E:2009 ||| VBD
tendency  ||| S:2009 E:2018 ||| NN
to  ||| S:2018 E:2021 ||| TO
the  ||| S:2021 E:2025 ||| DT
shift  ||| S:2025 E:2031 ||| NN
of  ||| S:2031 E:2034 ||| IN
proportion  ||| S:2034 E:2045 ||| NN
of  ||| S:2045 E:2048 ||| IN
energy-intensive  ||| S:2048 E:2065 ||| JJ
substrates  ||| S:2065 E:2076 ||| NNS
( ||| S:2076 E:2077 ||| -LRB-
fats  ||| S:2077 E:2082 ||| NNS
and  ||| S:2082 E:2086 ||| CC
carbohydrates ||| S:2086 E:2099 ||| CD
)  ||| S:2099 E:2101 ||| -RRB-
to  ||| S:2101 E:2104 ||| TO
deceleration  ||| S:2104 E:2117 ||| VB
of  ||| S:2117 E:2120 ||| IN
carbohydrate  ||| S:2120 E:2133 ||| JJ
oxidation  ||| S:2133 E:2143 ||| NNS
( ||| S:2143 E:2144 ||| -LRB-
in  ||| S:2144 E:2147 ||| IN
32 ||| S:2147 E:2149 ||| CD
,  ||| S:2149 E:2151 ||| ,
50 ||| S:2151 E:2153 ||| CD
,  ||| S:2153 E:2155 ||| ,
55.1 ||| S:2155 E:2159 ||| CD
%  ||| S:2159 E:2161 ||| NN
of  ||| S:2161 E:2164 ||| IN
children ||| S:2164 E:2172 ||| NNS
)  ||| S:2172 E:2174 ||| -RRB-
and  ||| S:2174 E:2178 ||| CC
compensatory  ||| S:2178 E:2191 ||| JJ
fat  ||| S:2191 E:2195 ||| JJ
oxidation  ||| S:2195 E:2205 ||| JJ
acceleration  ||| S:2205 E:2218 ||| NN
( ||| S:2218 E:2219 ||| -LRB-
8 ||| S:2219 E:2220 ||| CD
,  ||| S:2220 E:2222 ||| ,
28.4  ||| S:2222 E:2227 ||| CD
and  ||| S:2227 E:2231 ||| CC
34.7 ||| S:2231 E:2235 ||| CD
%  ||| S:2235 E:2237 ||| NN
respectively ||| S:2237 E:2249 ||| RB
) ||| S:2249 E:2250 ||| -RRB-
.  ||| S:2250 E:2252 ||| .
Mean  ||| S:2252 E:2257 ||| VB
fat  ||| S:2257 E:2261 ||| JJ
oxidation  ||| S:2261 E:2271 ||| JJ
rate  ||| S:2271 E:2276 ||| NN
levels  ||| S:2276 E:2283 ||| NNS
significantly  ||| S:2283 E:2297 ||| RB
differed  ||| S:2297 E:2306 ||| VBN
between  ||| S:2306 E:2314 ||| IN
groups  ||| S:2314 E:2321 ||| NNS
and  ||| S:2321 E:2325 ||| CC
increased  ||| S:2325 E:2335 ||| VBN
with  ||| S:2335 E:2340 ||| IN
age  ||| S:2340 E:2344 ||| NN
( ||| S:2344 E:2345 ||| -LRB-
48.38  ||| S:2345 E:2351 ||| CD
±  ||| S:2351 E:2353 ||| CD
7.14 ||| S:2353 E:2357 ||| CD
,  ||| S:2357 E:2359 ||| ,
54.29  ||| S:2359 E:2365 ||| CD
±  ||| S:2365 E:2367 ||| CD
3.06  ||| S:2367 E:2372 ||| CD
and  ||| S:2372 E:2376 ||| CC
78.43  ||| S:2376 E:2382 ||| CD
±  ||| S:2382 E:2384 ||| CD
2.89  ||| S:2384 E:2389 ||| CD
g ||| S:2389 E:2390 ||| CD
/ ||| S:2390 E:2391 ||| CD
day  ||| S:2391 E:2395 ||| NN
in  ||| S:2395 E:2398 ||| IN
children  ||| S:2398 E:2407 ||| NNS
of  ||| S:2407 E:2410 ||| IN
the  ||| S:2410 E:2414 ||| DT
1st ||| S:2414 E:2417 ||| CD
,  ||| S:2417 E:2419 ||| ,
2nd  ||| S:2419 E:2423 ||| NNP
and  ||| S:2423 E:2427 ||| CC
3rd  ||| S:2427 E:2431 ||| CD
groups  ||| S:2431 E:2438 ||| NNS
respectively ||| S:2438 E:2450 ||| RB
,  ||| S:2450 E:2452 ||| ,
p  ||| S:2452 E:2454 ||| CD
< ||| S:2454 E:2456 ||| SYM
0.001 ||| S:2456 E:2461 ||| CD
) ||| S:2461 E:2462 ||| -RRB-
.  ||| S:2462 E:2464 ||| .
The  ||| S:2464 E:2468 ||| DT
mean  ||| S:2468 E:2473 ||| JJ
level  ||| S:2473 E:2479 ||| NN
of  ||| S:2479 E:2482 ||| IN
carbohydrate  ||| S:2482 E:2495 ||| JJ
oxidation  ||| S:2495 E:2505 ||| JJ
rate  ||| S:2505 E:2510 ||| NN
in  ||| S:2510 E:2513 ||| IN
the  ||| S:2513 E:2517 ||| DT
3rd  ||| S:2517 E:2521 ||| JJ
group  ||| S:2521 E:2527 ||| NN
of  ||| S:2527 E:2530 ||| IN
children  ||| S:2530 E:2539 ||| NNS
was  ||| S:2539 E:2543 ||| VBD
lower  ||| S:2543 E:2549 ||| JJR
than  ||| S:2549 E:2554 ||| IN
normal  ||| S:2554 E:2561 ||| JJ
value  ||| S:2561 E:2567 ||| NN
( ||| S:2567 E:2568 ||| -LRB-
p  ||| S:2568 E:2570 ||| CD
< ||| S:2570 E:2572 ||| SYM
0.01 ||| S:2572 E:2576 ||| CD
) ||| S:2576 E:2577 ||| -RRB-
.  ||| S:2577 E:2579 ||| .
Resting  ||| S:2579 E:2587 ||| JJ
energy  ||| S:2587 E:2594 ||| NN
expenditure  ||| S:2594 E:2606 ||| NN
was  ||| S:2606 E:2610 ||| VBD
lower  ||| S:2610 E:2616 ||| JJR
in  ||| S:2616 E:2619 ||| IN
the  ||| S:2619 E:2623 ||| DT
2nd  ||| S:2623 E:2627 ||| NNP
and  ||| S:2627 E:2631 ||| CC
3rd  ||| S:2631 E:2635 ||| CD
groups  ||| S:2635 E:2642 ||| NNS
of  ||| S:2642 E:2645 ||| IN
children ||| S:2645 E:2653 ||| NNS
.  ||| S:2653 E:2655 ||| .
